2-[[7-[(3R)-3-aminopiperidin-1-yl]-3,5-dimethyl-2-oxoimidazo[4,5-b]pyridin-1-yl]methyl]benzonitrile manufacturers
- Imigliptin
-
- $1220.00
-
2026-05-12
- CAS:1314944-07-4
- Purity: 99.12%
- Supply Ability: 10g
|
| | 2-[[7-[(3R)-3-aminopiperidin-1-yl]-3,5-dimethyl-2-oxoimidazo[4,5-b]pyridin-1-yl]methyl]benzonitrile Basic information |
| | 2-[[7-[(3R)-3-aminopiperidin-1-yl]-3,5-dimethyl-2-oxoimidazo[4,5-b]pyridin-1-yl]methyl]benzonitrile Chemical Properties |
| Boiling point | 595.3±50.0 °C(Predicted) | | density | 1.34±0.1 g/cm3(Predicted) | | pka | 10.00±0.20(Predicted) |
| | 2-[[7-[(3R)-3-aminopiperidin-1-yl]-3,5-dimethyl-2-oxoimidazo[4,5-b]pyridin-1-yl]methyl]benzonitrile Usage And Synthesis |
| Uses | KBP-5493 (compound D) is an endogenous metabolite that can be detected in urine and plasma. | | References | [1] Liu Y, et al. Simultaneous determination of imigliptin and its three metabolites in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Oct 1;1002:300-12. DOI:10.1016/j.jchromb.2015.08.003 |
| | 2-[[7-[(3R)-3-aminopiperidin-1-yl]-3,5-dimethyl-2-oxoimidazo[4,5-b]pyridin-1-yl]methyl]benzonitrile Preparation Products And Raw materials |
|